688192 迪哲醫藥
按盤價 
57.500 +0.490 (+0.859%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -70.977 | -162.312 | -84.976 | -34.871 | -37.827 |
| 總資產報酬率 ROA (%) | -24.815 | -52.624 | -61.913 | -30.491 | -34.110 |
| 投入資產回報率 ROIC (%) | -30.024 | -64.724 | -71.379 | -33.498 | -36.913 | 邊際利潤分析 |
| 銷售毛利率 (%) | 95.681 | 97.411 | 96.478 | -- | 12.420 |
| 營業利潤率 (%) | -99.420 | -261.545 | -1,213.308 | -- | -6,512.850 |
| 息稅前利潤/營業總收入 (%) | -95.548 | -254.688 | -1,207.359 | -- | -6,441.487 |
| 淨利潤/營業總收入 (%) | -99.429 | -261.087 | -1,213.419 | -- | -6,512.850 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 111.199 | 106.098 | 104.851 | 106.708 | 101.841 |
| 價值變動淨收益/利潤總額(%) | -3.183 | -1.538 | -2.033 | -5.730 | -0.353 |
| 營業外收支淨額/利潤總額(%) | 0.000 | -0.176 | 0.000 | 0.000 | 0.000 | 償債能力分析 |
| 流動比率 (X) | 2.468 | 1.272 | 2.030 | 5.928 | 9.964 |
| 速動比率 (X) | 2.423 | 1.216 | 1.978 | 5.908 | 9.964 |
| 資產負債率 (%) | 51.148 | 88.360 | 43.288 | 15.535 | 10.304 |
| 帶息債務/全部投入資本 (%) | 41.104 | 82.011 | 27.806 | 0.561 | 0.660 |
| 股東權益/帶息債務 (%) | 139.664 | 17.448 | 242.222 | 17,006.872 | 14,625.948 |
| 股東權益/負債合計 (%) | 95.291 | 12.758 | 131.011 | 543.703 | 870.537 |
| 利息保障倍數 (X) | -24.679 | -39.802 | -202.965 | 90.190 | -90.264 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 35.598 | 37.778 | 189.449 | -- | 252.938 |
| 存貨周轉天數 (天) | 440.626 | 1,305.815 | 1,597.977 | -- | 0.000 |
| 備註： | 即時報價更新時間為 17/12/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
